TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Inro Biomedtek AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
488
|
376 | |
| Financial expenses |
1,252
|
7,380 | |
| Earnings before taxes |
-575
|
-6,976 | |
| EBITDA |
389
|
298 | |
| Total assets |
13,727
|
13,828 | |
| Current assets |
13,583
|
13,642 | |
| Current liabilities |
955
|
1,238 | |
| Equity capital |
12,771
|
12,590 | |
| - share capital |
101
|
95 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
93.0%
|
91.0% | |
| Turnover per employee |
488
|
376 | |
| Profit as a percentage of turnover |
-117.8%
|
-1855.3% | |
| Return on assets (ROA) |
4.9%
|
2.9% | |
| Current ratio |
1422.3%
|
1101.9% | |
| Return on equity (ROE) |
-4.5%
|
-55.4% | |
| Change turnover |
85
|
28 | |
| Change turnover % |
-10%
|
21%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.